119-HR-8983 Journalist Public Summary

Headline Summary

A bill to tighten use of state Prescription Drug Monitoring Programs (PDMPs) by veterinarians and to require reporting of non‑fatal overdoses within 72 hours, with the goal of reducing drug diversion and improving safety.

What It Does

- Brings veterinarians under the same PDMP rules as other prescribers: check the PDMP before prescribing any controlled substance and report any dispensing. - For animal prescriptions, vets would submit the owner or primary caretaker’s information to the PDMP instead of the pet’s. - Adds veterinarians to the federal definition of “dispenser” under the PDMP grant program. - Requires prescribers who intervene in a non‑fatal overdose to report that event to the PDMP within 72 hours. - Converts certain PDMP activities from optional to required in federal statute, signaling tighter program expectations. Why it matters: Supporters argue these steps close a known gap—“vet shopping” and other diversion risks—and provide earlier warnings that can help clinicians and public health officials respond. Opponents worry about added paperwork for clinics and potential privacy concerns when owner information is linked to pet prescriptions.

Who’s For It

• Sponsor: Rep. Cory Mills (R‑FL).
• Backers focused on combating opioid and controlled‑substance misuse say uniform PDMP use across human and veterinary care helps spot risky patterns sooner.
• Some public‑safety and public‑health advocates favor timely reporting of non‑fatal overdoses to improve outreach and prevention.

Who’s Against It

• Some veterinarians may oppose added administrative workload and compliance costs tied to PDMP checks and reporting.
• Privacy and civil‑liberties advocates could raise concerns about linking owner identities to pet prescriptions and about mandatory reporting of non‑fatal overdoses potentially discouraging people from seeking help.
• Clinicians and harm‑reduction groups may warn that new reporting mandates, if not paired with protections, could chill post‑overdose care‑seeking.

What’s Next

Status: Introduced on May 21, 2026, and referred to the House Committee on Energy and Commerce. Next steps would typically include a hearing and committee markup; if approved, the bill would move to a House floor vote, then to the Senate, and finally to the President if both chambers pass it.